Stay updated with breaking news from Antibiotic analog. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Search jobs 19-Feb-2021 Anti-Suicide Drugs Market to Exhibit a Rise by 4.1% CAGR Between 2019 to 2027 | Coherent Market Insights The Global Anti-Suicide Drugs Market, by Drug Class (Anti-Depressant and Anti-Anxiety Drugs, Anti-Psychotic Drugs, NMDA Antagonist, and Antibiotic Analog) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 3,818.1 million in 2018 and is projected to expand at a CAGR of 4.1% during the forecast period (2019–2027). Novel approved drugs, which are expected to be commercialized post-2020, introduced for the treatment of suicidal ideation is expected to drive the global anti-suicide drugs market growth. Until recently, suicidal ideation has been treated with anti-depressants, anti-anxiety, and anti-psychotic drugs. The trend is expected to continue till the expected launch of Cyclurad by NeruoRx Pharma during the ....